Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05944705Recruiting

Commercially Available Cannabis Products for Immune Support

Role: lead

NCT04944459Not ApplicableCompleted

Meditation Utilizing Signals From Electroencephalography in Chronic Pain (MUSE-PAIN) Study

Role: lead

NCT05511181Not ApplicableCompleted

BioWave High-frequency Neurostimulation Versus TENS for the Treatment of Chronic Low Back Pain

Role: collaborator

NCT04238598Not ApplicableCompleted

Intra-articular Pulsed Radiofrequency Neuromodulation Versus Intra-articular Steroids for Painful Knee Osteoarthritis

Role: lead

All 4 trials loaded